Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹10.53.
28 Oct: open ₹10.58, high ₹10.75, low ₹10.11
- Under NSE's long-term additional surveillance, stage I, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹201 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.35
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,29,85665.4% delivered
Nectar Lifesciences has 590 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 5 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Nectar Lifesciences quarterly results
The board met on 14 Aug 2026 to consider financial results and other business matters
Notice filed 10 Aug 2026
Nectar Lifesciences annual reports, presentations and earnings calls
The company's own documents, latest first.Nectar Lifesciences financials, year by year
Annual reports17
- Annual report, year to Mar 202620 Aug 2026
- Annual report, year to Mar 202526 Aug 2025
- Annual report, year to Mar 202414 Aug 2024
- Annual report, year to Mar 202311 Aug 2023, a zip file
- Annual report, year to Mar 202224 Aug 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202124 Aug 2021, a zip file
- Annual report, year to Mar 202014 Aug 2020, a zip file
- Annual report, year to Mar 201922 Aug 2019, a zip file
- Annual report, year to Mar 201829 Sep 2018, a zip file
- Annual report, year to Mar 20173 Oct 2017, a zip file
- Annual report, year to Mar 20164 Oct 2016, a zip file
- Annual report, year to Mar 201531 Aug 2015, a zip file
- Annual report, year to Mar 201422 Aug 2014, a zip file
- Annual report, year to Mar 201330 Aug 2013, a zip file
- Annual report, year to Mar 201218 Sep 2012, a zip file
- Annual report, year to Mar 201110 Sep 2011, a zip file
- Annual report, year to Mar 201031 Aug 2010, a zip file
Investor presentations3
- Investor Presentation (Q3 FY25)31 Jan 2025
- Investor Presentation14 Nov 2024
- Corporate Presentation of Business of the Company21 Oct 2024
Nectar Lifesciences share news and announcements
Newest first. Page 1 of 12.
Oct 2026
Sep 2026
19 Sep · General Updates
18 Sep · Meeting
Aug 2026
15 Aug · General Updates
14 Aug · Results
6 Aug · Management
4 Aug · General Updates
Jul 2026
23 Jul · General Updates
13 Jul · General Updates
May 2026
30 May · Results
Apr 2026
28 Apr · General Updates
8 Apr
Mar 2026
13 Mar · Meeting
6 Mar · Business
2 Mar · Board meeting
Feb 2026
Jan 2026
28 Jan · Meeting
23 Jan · Results
21 Jan · General Updates
13 Jan · Legal
Exchange has sought clarification from Nectar Lifesciences Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Dec 2025
29 Dec · Updates
29 Dec · Buyback
20 Dec · General Updates
10 Dec · Public Announcement - Buyback of Shares
3 Dec · Board meeting
Nov 2025
27 Nov · Board meeting
14 Nov · Board meeting
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 17 Aug 2026Resultsup 2.09%+2.2 pts vs Nifty 500market median −0.7% · five sessions −4.8% (−4.5 pts vs Nifty 500) · volume 2.0× usual · The announcement
- 7 Aug 2026Board or managers changedup 0.76%+0.8 pts vs Nifty 500market median 0.0% · five sessions +8.0% (+8.3 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 1 Jun 2026Resultsdown 2.89%−1.9 pts vs Nifty 500market median −0.7% · five sessions −3.8% (−2.9 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 27 Jan 2026Resultsdown 4.58%−5.1 pts vs Nifty 500market median −0.7% · five sessions −8.8% (−8.3 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 16 Jan 2026Buybackdown 2.82%−2.9 pts vs Nifty 500market median 0.0% · five sessions −6.7% (−4.7 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 29 Dec 2025Buybackdown 4.98%−4.6 pts vs Nifty 500market median 0.0% · five sessions +0.1% (−1.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 10 Dec 2025Buybackup 0.67%+1.1 pts vs Nifty 500market median 0.0% · five sessions +1.4% (+1.2 pts vs Nifty 500) · volume 0.6× usual · delivery +8.6 pts against usual · The announcement
- 5 Dec 2025Buybackup 0.05%−0.3 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+0.8 pts vs Nifty 500) · volume 2.1× usual · delivery −6.6 pts against usual · The announcement
- 17 Nov 2025Resultsdown 1.02%−1.5 pts vs Nifty 500market median −0.7% · five sessions +0.3% (+0.5 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 12 Nov 2025Board or managers changeddown 2.48%−3.1 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−6.1 pts vs Nifty 500) · volume 2.0× usual · The announcement
20 earlier announcements
- 10 Nov 2025Board or managers changedup 1.43%+1.1 pts vs Nifty 500market median 0.0% · five sessions +0.5% (−0.9 pts vs Nifty 500) · volume 2.5× usual · The announcement
- 6 Nov 2025Board or managers changed0.00%+0.7 pts vs Nifty 500market median 0.0% · five sessions +1.0% (+0.3 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 18 Aug 2025Resultsup 4.06%+3.0 pts vs Nifty 500market median −0.7% · five sessions +9.3% (+7.9 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 2 Apr 2025Board or managers changedup 3.53%+2.6 pts vs Nifty 500market median 0.0% · five sessions −3.4% (−0.6 pts vs Nifty 500) · volume 0.9× usual · delivery −3.6 pts against usual · The announcement
- 28 Feb 2025Board or managers changeddown 3.20%−1.1 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+4.5 pts vs Nifty 500) · volume 1.6× usual · delivery +16.7 pts against usual · The announcement
- 1 Feb 2025Resultsup 4.98%+5.0 pts vs Nifty 500market median −0.7% · five sessions +6.9% (+6.4 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 14 Nov 2024Resultsup 2.00%+1.8 pts vs Nifty 500market median −0.7% · five sessions −2.8% (−4.3 pts vs Nifty 500) · volume 11.0× usual · The announcement
- 30 Sep 2024Board or managers changeddown 1.07%−0.1 pts vs Nifty 500market median 0.0% · five sessions −2.7% (+2.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 14 Aug 2024Resultsdown 0.10%0.0 pts vs Nifty 500market median −0.7% · five sessions +23.5% (+20.5 pts vs Nifty 500) · volume 2.0× usual · delivery −20.6 pts against usual · The announcement
- 15 May 2024Resultsup 9.16%+8.9 pts vs Nifty 500market median −0.7% · five sessions +1.8% (−0.6 pts vs Nifty 500) · volume 10.0× usual · delivery −35.2 pts against usual · The announcement
- 12 Jan 2024Board or managers changedup 1.48%+0.7 pts vs Nifty 500market median 0.0% · five sessions +2.4% (+3.2 pts vs Nifty 500) · volume 1.3× usual · delivery −3.2 pts against usual · The announcement
- 14 Aug 2023Resultsdown 7.49%−7.3 pts vs Nifty 500market median −0.7% · five sessions −7.9% (−7.8 pts vs Nifty 500) · volume 1.2× usual · delivery −13.4 pts against usual · The announcement
- 15 Nov 2022Board or managers changeddown 3.27%−3.6 pts vs Nifty 500market median 0.0% · five sessions −6.5% (−5.3 pts vs Nifty 500) · volume 2.2× usual · delivery −2.6 pts against usual · The announcement
- 23 Aug 2022Board or managers changeddown 0.87%−1.5 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+0.2 pts vs Nifty 500) · volume 1.0× usual · delivery −1.8 pts against usual · The announcement
- 16 Aug 2022Resultsdown 2.04%−3.0 pts vs Nifty 500market median −0.7% · five sessions −6.5% (−5.6 pts vs Nifty 500) · volume 1.4× usual · delivery +12.4 pts against usual · The announcement
- 11 Jul 2022Board or managers changedup 1.26%+0.8 pts vs Nifty 500market median 0.0% · five sessions +1.5% (+1.7 pts vs Nifty 500) · volume 0.8× usual · delivery −10.2 pts against usual · The announcement
- 31 May 2022Resultsup 3.15%+3.4 pts vs Nifty 500market median −0.7% · five sessions −0.4% (+0.3 pts vs Nifty 500) · volume 1.4× usual · delivery +4.2 pts against usual · The announcement
- 9 May 2022Board or managers changeddown 1.68%−0.6 pts vs Nifty 500market median 0.0% · five sessions −8.4% (−3.6 pts vs Nifty 500) · volume 0.4× usual · delivery −17.7 pts against usual · The announcement
- 6 May 2022Board or managers changeddown 2.37%−0.6 pts vs Nifty 500market median 0.0% · five sessions −12.9% (−6.5 pts vs Nifty 500) · volume 0.3× usual · delivery −12.7 pts against usual · The announcement
- 16 Aug 2021Resultsdown 3.23%−3.3 pts vs Nifty 500market median −0.7% · five sessions −9.5% (−8.6 pts vs Nifty 500) · volume 0.8× usual · delivery −0.2 pts against usual · The announcement
Nectar Lifesciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.